|
Title
|
|
|
|
1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more potent than the parent compound 3. Moreover, contrary to the latter, amide analogue 4g was active against the avirulent M. tuberculosis H37Ra strain (MIC50=35 µM). This finding opens avenues for future modifications. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Journal of enzyme inhibition and medicinal chemistry. - London
|
|
|
Publication
|
|
|
|
London
:
2019
|
|
|
ISSN
|
|
|
|
1475-6366
1475-6374
|
|
|
DOI
|
|
|
|
10.1080/14756366.2019.1662790
|
|
|
Volume/pages
|
|
|
|
34
:1
(2019)
, p. 1730-1739
|
|
|
ISI
|
|
|
|
000664918600001
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|